Investigating biomarkers of Staphylococcus aureus bacteremia in patients - School of Pharmacy
Por um escritor misterioso
Descrição
The Centers for Disease Control identifies methicillin-resistant S. aureus (MRSA) as a serious health threat with greater than 100,000 invasive infections and 20,000 patient deaths annually in the United States. Despite recent advancements in available treatment options for methicillin-sensitive S.
Antibiotics, Free Full-Text
Multifunctional lipid-based nanocarriers with antibacterial and anti‐inflammatory activities for treating MRSA bacteremia in mice, Journal of Nanobiotechnology
Frontiers Staphylococcus aureus Vaccine Research and Development: The Past, Present and Future, Including Novel Therapeutic Strategies
Frontiers Practice Summary of Antimicrobial Therapy for Commonly Encountered Conditions in the Neonatal Intensive Care Unit: A Canadian Perspective
Frontiers Clinical Characteristics of Bloodstream Infection in Immunosuppressed Patients: A 5-Year Retrospective Cohort Study
Investigating biomarkers of Staphylococcus aureus bacteremia in patients - School of Pharmacy
Vascular Proteome Responses Precede Organ Dysfunction in a Murine Model of Staphylococcus aureus Bacteremia
2023 ACCP Annual Meeting November 11 ‐ 14, 2023 - 2023 - JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY - Wiley Online Library
Antibiotics, Free Full-Text
de
por adulto (o preço varia de acordo com o tamanho do grupo)
